Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
07/15/2009 | EP1871738B1 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
07/15/2009 | EP1844039B1 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics |
07/15/2009 | CN101481368A Production method of 5-norbornene-2,3-anhydride |
07/15/2009 | CN101481367A Method for synthesizing natural sesquiterpene Crepis virens extract (8-Epigrosheimin) |
07/15/2009 | CN101481366A Preparation of 2,3,3',4'-biphenyl-tetracarboxylic acid dianhydride and derivatives thereof |
07/15/2009 | CN101480183A Selective herbicides based on substituted arylsulfonylaminocarbonyl triazolinones and safeners |
07/15/2009 | CN100513402C Method for producing 2-oxo-1-phenyl-3-oxabicyclo [3.1.0]hexane |
07/15/2009 | CN100513381C Process for preparation of cyclic diketones |
07/15/2009 | CN100512810C Premixed amiodarone parenteral solution and method for making the same |
07/15/2009 | CN100512809C Compounds and methods of treating transplant rejection |
07/14/2009 | US7560589 Cycloalkylidene compounds as modulators of estrogen receptor |
07/14/2009 | US7560582 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
07/14/2009 | US7560576 Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
07/14/2009 | US7560572 Therapy for micorbiocide infections; cystic fibrosis; controlling gene expression; antibiotic; immunology stimulant |
07/14/2009 | US7560483 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable |
07/14/2009 | US7560463 Diaryl ethers as opioid receptor antagonists |
07/09/2009 | WO2009085344A2 Dibenzothiophene, dibenzofuran and/or carbazole-containing materials in phosphorescent light emitting diodes |
07/09/2009 | WO2009084655A1 METHOD FOR PRODUCING 4'-ETHYNYL d4T |
07/09/2009 | WO2009084512A1 Aromatic amine derivative and organic electroluminescent device using the same |
07/09/2009 | WO2009084023A2 Amorphous ramelteon and process for the preparation thereof |
07/09/2009 | WO2009084008A1 Process for preparing mycophenolate mofetil |
07/09/2009 | WO2009028969A9 Lignin and other products isolated from plant material, and methods and compositions therefor |
07/09/2009 | WO2008148747A3 Pdz domain modulators |
07/09/2009 | US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism |
07/09/2009 | US20090176990 Process for producing nitroguanidine derivatives |
07/09/2009 | US20090176895 Multi-Tubular Reactors With Monolithic Catalysts |
07/09/2009 | US20090176873 Novel use of organic compounds |
07/09/2009 | US20090176861 Cathepsin cysteine protease inhibitors |
07/09/2009 | US20090176859 Cathepsin cysteine protease inhibitors |
07/09/2009 | US20090176848 Fortifier |
07/09/2009 | US20090176837 Compounds with activity at retinoic acid receptors |
07/09/2009 | US20090176836 3-{[(3-amino-3-benzyltetrahydrofuran-2-yl)oxy]methyl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[(methylsulfonyl)(propyl)amino]benzamide, used for preventing the formation of insoluble amyloid proteins |
07/09/2009 | US20090176786 Benzoylurea Compounds and Use Thereof |
07/08/2009 | EP2076491A1 New benzamide derivatives as bradykinin antagonists |
07/08/2009 | EP2076252A2 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
07/08/2009 | EP2076132A1 P-toluene sulfonic acid salt of 5-amino-3-(2'-o-acetyl-3'-deoxy-beta -d-ribofuranosyl)-3h-thiazole [4, 5-d]pyrimidine-2-one and methods for preparation |
07/08/2009 | CN101475548A Method for preparing chiral 3-substituted phthalide compound |
07/08/2009 | CN101475547A Method for synthesizing furanol by catalyzing basic ferric carboxylate |
07/08/2009 | CN101475546A Catalytic synthesis process of benzofurane derivatives |
07/08/2009 | CN101475545A Method for preparing alpha-angelica lactone from acetylpropionic acid |
07/08/2009 | CN101475544A Method for preparing furan chemical by catalytic pyrolysis of biomass |
07/08/2009 | CN101475543A Method for preparing hydroxymethyl-furfural from glucide under low temperature and normal pressure |
07/08/2009 | CN100510093C Method for preparing 3-heteroarylradical-3-hydroxy-propionic acid derivative |
07/08/2009 | CN100509877C Unsaturated monomers, polymers, chemically amplified resist composition, and process of pattern formation |
07/08/2009 | CN100509816C Method for preparing a composition containing at least an internal dehydrating product of a hydrogenated sugar |
07/08/2009 | CN100509791C Compound and use of the compound as glycine transport inhibitors |
07/08/2009 | CN100509759C Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
07/07/2009 | US7557249 Spirobifluorene derivatives, their preparation and uses thereof |
07/07/2009 | US7557223 Titanium-vanadium-tin comprising catalyst and process for the preparation of phthalic anhydride |
07/07/2009 | US7557219 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
07/07/2009 | US7557140 e.g. 3-[3-(2,4-Difluoro-phenylsulfamoyl)-phenyl]-N-hydroxy-acrylamide; histone deacetylase inhibitor; anticarcinogenic, antiinflammatory agent, autoimmune diseases; leukemia, atheriosclerosis, Alzheimer's disease, rheumatoid arthritis, psoriasis |
07/07/2009 | US7556931 Furosemide modulators of HM74 |
07/07/2009 | US7556908 Chemically amplified positive resist composition, (meth)acrylate derivative and a process for producing the same |
07/02/2009 | WO2009082347A1 Bis- (sulf onylamino) derivatives for use in therapy |
07/02/2009 | WO2009081483A1 Oxime esters and photopolymerization initiators containing the same |
07/02/2009 | WO2009080773A1 Convergent synthesis of renin inhibitors and intermediates useful therein |
07/02/2009 | WO2009056993A3 A process for the synthesis of ramelteon and its intermediates |
07/02/2009 | WO2009052970A3 Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors |
07/02/2009 | US20090171101 Method for gas phase oxidation using a moderator layer |
07/02/2009 | US20090171095 Production method of heterocyclic mercapto compound |
07/02/2009 | US20090170941 Pharmaceutical Compounds |
07/02/2009 | US20090170902 Compounds which potentiate glutamate receptor and uses thereof in medicine |
07/02/2009 | US20090170895 S1p3 receptor antagonist |
07/02/2009 | US20090170883 3-arylphenyl sulfide derivative and insecticide and miticide |
07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
07/02/2009 | US20090170108 Screening method, a composition comprising substances chosen in the method thereof, and a binding substance |
07/02/2009 | DE102007063507A1 Verfahren zur Herstellung von Carbonsäureestern Process for the preparation of carboxylic acid esters |
07/02/2009 | CA2709510A1 Bis-(sulfonylamino) derivatives for use in therapy |
07/01/2009 | EP2075247A1 Fluorinated monomer having cyclic structure, manufaturing method, polymer, photoresist composition and patterning process |
07/01/2009 | EP2075244A1 New route to building block for making renin inhibitors |
07/01/2009 | EP2074107A2 Tricyclic compounds as matrix metalloproteinase inhibitors |
07/01/2009 | EP2074106A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10 |
07/01/2009 | EP2074102A1 2-phenyl indene derivatives useful as estrogen receptor ligands |
07/01/2009 | EP2074097A2 Compounds for treating proliferative disorders |
07/01/2009 | EP1756043B1 Ortho substituted aryl or heteroaryl amide compounds |
07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
07/01/2009 | EP1487577B1 Catalyst-precursor for the production of maleic acid anhydride and method for the production thereof |
07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
07/01/2009 | EP1406858B1 Substituted 4-aminocyclohexanols |
07/01/2009 | CN101468975A High-purity salvianolic acid B, preparation and use thereof |
07/01/2009 | CN100506812C Method for producing furol by extruding plant stalk |
07/01/2009 | CN100506788C Arylalkylcarbamate derivatives production and use thereof in therapy |
06/30/2009 | US7553988 Method for producing coupling compound |
06/30/2009 | US7553970 Process for preparing 3-heteroaryl-3-hydroxypropanoic acid derivatives |
06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
06/30/2009 | US7553831 Beta-secretase inhibitors; inhibiting cleavage of amyloid precursor protein (APP); hydroxy-functional disubstituted amines such as 6-(([[(2S,3S)-4-(3,5-difluorophenyl)-3-((3-[(dipropylamino)carbonyl]benzoyl)amino)-2-hydroxybutyl](ethyl)amino]carbonyl)amino)hexanoic acid |
06/30/2009 | CA2406088C Novel phenyl-propargylether derivatives |
06/25/2009 | WO2009079597A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
06/25/2009 | WO2009077677A2 Novel polyspirane compounds, application thereof in the treatment of malaria or toxoplasmosis and method for preparing same |
06/25/2009 | WO2009077606A2 Gasoline composition and process for the preparation of alkylfurfuryl ether |
06/25/2009 | WO2009077587A1 Furan based resin, process for the preparation thereof, and use of the compound |
06/25/2009 | WO2009076869A1 Salvianolic acid of high purity, preparation method and use thereof |
06/25/2009 | WO2009061744A3 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
06/25/2009 | WO2009044143A3 Process for preparing benzofurans |
06/25/2009 | WO2009041705A3 5-membered heterocyclic compounds as proton pump inhibitors |
06/25/2009 | US20090163726 Catalyst system for preparing carboxylic acids and/or carboxylic anhydrides |
06/25/2009 | US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma |
06/25/2009 | US20090163586 Bis-(Sulfonylamino) Derivatives in Therapy 205 |